The BTA stat test is a “point-of-care” rapid immunochromatographic assay for detecting the bladder tumour antigen (BTA) in the urine. 17 The BTA stat test is one of non-invasive tumour markers in the urine and has become a useful marker in bladder cancer detection. 16 The antigen detected is a human complement factor-H related protein. 17 ...

Bladder Tumor Antigen (BTA) test, a non-invasive urine test used for detecting bladder cancer. Understand the normal range, test procedure, associated conditions, and treatment options for abnormal results. Discover prevention tips and the cost of the BTA test.

A commercial assay that have been used in this context is the bladder tumor antigen (BTA) test, which detects urinary complement factor H-related proteins, using monoclonal antibodies (1,2).

Nov 15, 2023 · Two BTA assays are currently approved by the FDA for BCa initial diagnosis and surveillance: the qualitative BTA test (BTA-Stat) and the quantitative BTA test (BTA-TRAK). 7 BTA-Stat is a point-of-care rapid immunochromatographic assay that provides results within 5 min, while BTA-TRAK is an enzyme-linked immunosorbent assay (ELISA) assay. 8 In ...

The bladder tumour antigen (BTA) test is used in the detection of bladder cancer. It works by detecting raised levels of complement factor H‐related protein (CFHrp), which is produced by cancer cells, in urine.

The BTA stat® Test is a non-invasive test used to detect bladder cancer in human urine. It uses monoclonal antibodies to detect the presence of bladder tumor-associated antigen in urine. For the lab, it is a simple, one-step test that has a 5-minute read time.

Bladder tumour antigen test. A qualitative, point-of-care test that identifies a human complement factor H-related protein, which is produced by several human bladder cell lines but not by non-malignant epithelial cell lines.

Recent studies suggest that the bladder tumor antigen (BTA) test, an agglutination reaction for basement membrane complexes, is superior to voided urine cytology in clinical practice.

The Status BTA test is an in vitro immunoassay intended for the qualitative detection of bladder tumor associated antigen in urine of persons diagnosed with bladder cancer. The test is indicated for use as an aid in the manage-

Der Blasentumor-Test ist ein qualitativer Test für den immun-chromatografischen Nachweis eines Blasentumorantigens (BTA) im menschlichen Urin. Der Nutzen für den Patient. Der BTA-Test ist eine sichere und schnell durchführbare Maßnahme um den Blasenkrebs frühzeitig erkennen und behandeln zu können.